Sayegh, Nicolas
Yirerong, Juliet
Agarwal, Neeraj
Addison, Daniel
Fradley, Michael
Cortes, Jorge
Weintraub, Neal L.
Sayed, Nazish
Raval, Girindra
Guha, Avirup http://orcid.org/0000-0003-0253-1174
Funding for this research was provided by:
National Heart, Lung, and Blood Institute
American Heart Association
Article History
Accepted: 6 February 2023
First Online: 16 February 2023
Compliance with Ethical Standards
:
: Neeraj Agarwal reports personal fees from Astellas, Astra Zeneca, Aveo, Bayer, Bristol Myers Squibb, Calithera, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genentech, Gilead, Janssen, Merck, MEI Pharma, Nektar, Novartis, Pfizer, Pharmacyclics, Seattle Genetic. They also report grants from Astellas, Astra Zeneca, Bavarian Nordic, Bayer, Bristol Myers Squibb, Calithera, Celldex, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Genentech, Gilead, Glaxo Smith Kline, Immunomedics, Janssen, Medivation, Merck, Nektar, New Link Genetics, Novartis, Pfizer, Prometheus, Rexahn, Roche, Sanofi, Seattle Genetics, Takeda, and Tracon, outside the submitted work. Daniel Addison reports grants from American Heart Association, NHLBI-NIH, and Pelotonia, outside the submitted work. Jorge Cortes reports grants and personal fees from BMS, Novartis, Pfizer, Takeda, Daiichi, Jazz Pharmaceuticals, Merus, and Forma Therapeutics; grants from Astellas and Amphivena; and personal fees from BiolineRx and Bioptah, outside the submitted work. Neal L Weintraub reports grants from NIH-NHLBI and the American Heart Association, outside the submitted work. Nazish Sayed reports grants from NIH-NHLBI and the American Heart Association, outside the submitted work. Avirup Guha reports personal fees from Pfizer/Myovant and grants from the American Heart Association, outside the submitted work. The other authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.